Agilent Technologies Inc (NYSE:A) stock rose 3.37% (As on May 29, 11:25:15 AM UTC-4, Source: Google Finance) after the company reporting fiscal second-quarter results that beat expectations and maintaining its full-year adjusted earnings guidance, despite margin pressure from tariffs and uneven demand across end markets. As of April 30, 2025, Agilent’s cash and cash equivalents were $1.49 billion, up from $1.47 billion as of Jan. 31, 2025. Accounts receivables were $1.36 billion at the end of the second quarter of fiscal 2025 compared with $1.33 billion at the end of the fiscal first quarter. The long-term debt was $3.349 billion for the reported quarter compared with $3.347 billion in the prior quarter. Cash flow from operating activities was $652 million in the second quarter of fiscal 2025 compared with $431 million in the previous quarter.

Moreover, the Life Sciences and Diagnostics Markets Group (LDG) reported second-quarter revenue of $654 million, an increase of 8% reported and 3% core year-over-year. The Agilent CrossLab Group (ACG) reported second-quarter revenue of $713 million, an increase of 7% reported and 9% core year-over-year. The Applied Markets Group (AMG) reported second-quarter revenue of $301 million, a decrease of 1% reported and flat core year-over-year.

A in the second quarter of FY25 has reported the adjusted earnings per share of $1.31, beating the analysts’ estimates for the adjusted earnings per share of $1.26, according to the Zacks Consensus Estimate. The company had reported the adjusted revenue growth of 6 percent to $1.67 billion in the second quarter of FY25, beating the analysts’ estimates for revenue of $1.63 billion. Organic growth reached 5.3%, exceeding the guided range of 2.5% to 5%. The non-GAAP operating margin was of 25.1% for the fiscal second quarter of 2025. Segment-wise, the operating margin in the LDG segment increased 70 bps to 19.7% from the prior-year quarter. ACG’s operating margin fell 10 bps year over year to 32.4%. Meanwhile, AMG’s operating margin contracted 140 bps year over year to 19.5%.

For the third quarter of fiscal 2025, management expects revenues of $1.645-$1.675 billion, indicating a rise of 4.2% to 6.1% on a reported basis and up 1.7% to 3.6% on a core basis. Non-GAAP fiscal third-quarter earnings per share are expected to be in the range of $1.35-$1.37. For fiscal 2025, management revised its revenue guidance from $6.68-$6.76 billion to $6.73-$6.81 billion, implying an increase of 3.4-4.6% on a reported basis and 2.5-3.5% on a core basis. The company reaffirmed its fiscal 2025 non-GAAP earnings per share guidance at $5.54-$5.61.